ArticleMalaria journal2015
Establishing a China malaria diagnosis reference laboratory network for malaria elimination.
Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- Misidentification of Plasmodium ovale as Plasmodium vivax malaria by a microscopic method: a meta-analysis of confirmed P. ovale cases.Scientific reports · 2020Pooled it
- Development of human resources in malaria microscopy during and after the malaria elimination phase in China.Scientific reports · 2026Article
- Competency of malaria laboratory diagnosis at national and provincial levels at the beginning of malaria post-elimination phase, China.Malaria journal · 2024Article
- Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004-2018.BMC public health · 2023Article
- Molecular detection and species identification of Plasmodium spp. infection among imported cases in Eastern China, 2012-2018.Parasitology research · 2023Article
- 1-3-7 surveillance and response approach in malaria elimination: China's practice and global adaptions.Malaria journal · 2023Review
- Insights into the elimination of vivax malaria in China.Infectious diseases of poverty · 2023Article
- Evaluation of performance for malaria diagnosis in health facilities by five provincial reference laboratories of China.Frontiers in public health · 2023Article
- Evolution of anti-malaria policies and measures in P.R. China for achieving and sustaining malaria-free.Frontiers in public health · 2023Review
- Establishing and applying an adaptive strategy and approach to eliminating malaria: practice and lessons learnt from China from 2011 to 2020.Emerging microbes & infections · 2022Article
- What India can learn from globally successful malaria elimination programmes.BMJ global health · 2022Article
- Prompt and precise identification of various sources of infection in response to the prevention of malaria re-establishment in China.Infectious diseases of poverty · 2022Article
- Key takeaways from China's success in eliminating malaria: leveraging existing evidence for a malaria-free world.BMJ global health · 2022Article
- Laboratory diagnosis for malaria in the elimination phase in China: efforts and challenges.Frontiers of medicine · 2022Review
- Malaria Microscopy Competency in the Subnational Verification, China: Implications for Malaria Elimination and the Prevention of Malaria Reestablishment.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022Article
- Prediction of the CYP2D6 enzymatic activity based on investigating of the CYP2D6 genotypes around the vivax malaria patients in Yunnan Province, China.Malaria journal · 2021Article
- Assessment on the Diagnostic Capacity for Parasitic Diseases of Health Facilities - China, 2019.China CDC weekly · 2021Article
- From malaria elimination to post-elimination: a 10-year surveillance data study in Shanghai.Malaria journal · 2021Article
- Antimalarial Drug Resistance Surveillance in China, 2016-2020.China CDC weekly · 2021Article
- From 30 million to zero malaria cases in China: lessons learned for China-Africa collaboration in malaria elimination.Infectious diseases of poverty · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn China, the prevalence of malaria has reduced dramatically due to the elimination programme. The continued success of the programme will depend upon the accurate diagnosis of the disease in the laboratory. The basic requirements for this are a reliable malaria diagnosis laboratory network and quality management system to support case verification and source tracking.
methodsThe baseline information of provincial malaria laboratories in the China malaria diagnosis reference laboratory network was collected and analysed, and a quality-assurance activity was carried out to assess their accuracies in malaria diagnosis by microscopy using WHO standards and PCR.
resultsBy the end of 2013, nineteen of 24 provincial laboratories have been included in the network. In the study, a total of 168 staff were registered and there was no bias in their age, gender, education level, and position. Generally Plasmodium species were identified with great accuracy by microscopy and PCR. However, Plasmodium ovale was likely to be misdiagnosed as Plasmodium vivax by microscopy.
conclusionsChina has established a laboratory network for primary malaria diagnosis which will cover a larger area. Currently, Plasmodium species can be identified fairly accurately by microscopy and PCR. However, laboratory staff need additional trainings on accurate identification of P. ovale microscopically and good performance of PCR operations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.